Ossur hf
CSE:OSSR
Relative Value
There is not enough data to reliably calculate the relative value of OSSR.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
OSSR Competitors Multiples
Ossur hf Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IS |
O
|
Ossur hf
CSE:OSSR
|
11.3B DKK | 2.2 | 31.3 | 16.4 | 24.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192B USD | 4.3 | 29.4 | 16.7 | 22.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.6B USD | 17.3 | 61.1 | 46.6 | 56.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
136.5B USD | 5.4 | 42.1 | 21.4 | 25.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.8B USD | 3.8 | 27.7 | 15.5 | 22.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
112.1B USD | 5.8 | 40.2 | 23.9 | 32.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.8B USD | 2.7 | 35.6 | 13 | 22.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46B EUR | 2 | 21.7 | 12.3 | 17.4 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.6B USD | 12 | 48.7 | 34.8 | 38.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD | 7.7 | 33.2 | 23.6 | 25.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
39.5B USD | 7.3 | 26.6 | 18.8 | 20.9 |